The potential impact of enhanced hygienic measures during the COVID-19 outbreak on hospital-acquired infections: A pragmatic study in neurological units.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 11 2020
Historique:
received: 07 07 2020
revised: 12 08 2020
accepted: 26 08 2020
pubmed: 7 9 2020
medline: 15 12 2020
entrez: 6 9 2020
Statut: ppublish

Résumé

Hospital-acquired infections (HAIs) are frequent complications among acute patients hospitalized in neurological units, especially among those hospitalized for stroke. This study aimed to investigate if enhanced hygienic measures, including the systematic use of personal protective equipment (PPE), determined a decrease in HAI during the recent COVID-19 outbreak in "COVID-free" neurological units. Patients hospitalized in neurology and stroke units of Policlinico Umberto I Hospital in Rome from March 8, 2020 and discharged prior to May 31, 2020 were included in the study and compared with patients hospitalized during the same period in 2019. A total of 319 patients were included in the study (n = 103 in 2020, n = 216 in 2019). Among patients hospitalized in 2019, the incidence of HAIs was 31.5% (95% confidence interval (CI): 0.25-0.38), compared with 23.3% (95% CI: 0.15-0.32) in 2020 (p = 0.12). Multivariable logistic regression showed that hospitalization during 2020 was independently associated with a lower risk of HAIs (odds ratio: 0.34, 95% CI:0.16-0.71, p = 0.004). Poisson regression models showed that hospitalization during 2020 was also independently associated with both a lower number of HAIs (relative risk [RR]: 0.56, 95% CI:0.38-0.81, p = 0.01) and a lower number of prescribed antibiotics per patient (RR: 0.66, 95% CI: 0.49-0.87, p = 0.02). Our study design provides evidence regarding the impact of stricter hygienic measures, such as increased PPE use, on HAIs. Larger studies are needed to support the extension of preventive measures even after the COVID-19 outbreak in order to limit the occurrence of HAIs.

Identifiants

pubmed: 32892033
pii: S0022-510X(20)30448-2
doi: 10.1016/j.jns.2020.117111
pmc: PMC7833504
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117111

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Références

Niger Med J. 2012 Apr;53(2):59-64
pubmed: 23271847
J Hosp Infect. 2009 Dec;73(4):305-15
pubmed: 19720430
Infect Drug Resist. 2018 Nov 15;11:2321-2333
pubmed: 30532565
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10484-10491
pubmed: 32327608
Eur J Neurol. 2004 Jan;11(1):49-53
pubmed: 14692888
J Hosp Infect. 2020 Aug;105(4):776-777
pubmed: 32201339
Disaster Med Public Health Prep. 2020 Jun;14(3):372-376
pubmed: 32207676
Lancet Neurol. 2008 Apr;7(4):341-53
pubmed: 18339349
Infection. 2008 Mar;36(2):112-9
pubmed: 18327681
Antimicrob Resist Infect Control. 2014 Jul 25;3:23
pubmed: 25075308

Auteurs

Emanuele Cerulli Irelli (E)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy.

Biagio Orlando (B)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy.

Enrico Cocchi (E)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Alessandra Morano (A)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy.

Francesco Fattapposta (F)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy.

Vittorio Di Piero (V)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy.

Danilo Toni (D)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy.

Maria R Ciardi (MR)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Italy.

Anna T Giallonardo (AT)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy.

Giovanni Fabbrini (G)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy; IRCCS Neuromed, Pozzilli, IS, Italy.

Alfredo Berardelli (A)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy; IRCCS Neuromed, Pozzilli, IS, Italy.

Carlo Di Bonaventura (C)

Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Italy. Electronic address: c_dibonaventura@yahoo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH